Search

Your search keyword '"Litchfield, Kevin"' showing total 377 results

Search Constraints

Start Over You searched for: Author "Litchfield, Kevin" Remove constraint Author: "Litchfield, Kevin"
Sorry, I don't understand your search. ×
377 results on '"Litchfield, Kevin"'

Search Results

1. MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

2. Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer

3. Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages

6. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

7. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models

10. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer

11. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

12. The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC

13. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

14. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

15. Genomic–transcriptomic evolution in lung cancer and metastasis

16. Lung adenocarcinoma promotion by air pollutants

17. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

18. Melanoma dedifferentiation induced by interferon-gamma epigenetic remodeling in response to anti-PD-1 therapy

19. Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy.

20. Pervasive chromosomal instability and karyotype order in tumour evolution

21. Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

22. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study

23. Vitamin D regulates microbiome-dependent cancer immunity

25. Using DNA sequencing data to quantify T cell fraction and therapy response

27. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study

28. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.

29. Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer

30. Cancer Associated Bacteria in Primary and Metastatic Non-Small Cell Lung Cancer

31. Pharmacologic Inhibition of Nonsense-Mediated Decay Induces Anti-Tumour Immunogenicity in Ex Vivo Patient Tumours

33. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma

34. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

36. The T cell differentiation landscape is shaped by tumour mutations in lung cancer

38. Quantifying the impact of immunotherapy on RNA dynamics in cancer

39. Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages

40. Whole-genome sequencing uncovers the genomic determinants of therapeutic resistance to immune checkpoint blockade

41. Supplementary Table 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides

42. Figure 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides

43. Figure 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides

44. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

45. Genomic landscape of platinum resistant and sensitive testicular cancers

47. Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

48. Supplementary Tables S1-S8 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

49. Supplementary Figures S1-S25 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

50. Supplementary figures from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides

Catalog

Books, media, physical & digital resources